Skip to main content
. 2020 Oct 19;4:CCI.20.00084. doi: 10.1200/CCI.20.00084

FIG 4.

FIG 4.

Treatment comparisons of immune checkpoint inhibitors (ICIs) versus historic controls. Median survival is represented by the dashed lines and reported in the legend. 1L, first line; 2L+, second or subsequent line; OS, overall survival; NSCLC, non–small-cell lung cancer; RCC, renal cell carcinoma.